Gene Symbol | Gene ID | Gene Info |
---|---|---|
GATA3
|
ENSG00000107485.11 | GATA binding protein 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_8284374_8284525 | GATA3 | 187680 | 0.030919 | 0.93 | 2.4e-04 | Click! |
chr10_8128417_8128568 | GATA3 | 31723 | 0.250434 | 0.86 | 2.8e-03 | Click! |
chr10_8259283_8259434 | GATA3 | 162589 | 0.039837 | 0.86 | 3.2e-03 | Click! |
chr10_8110062_8110213 | GATA3 | 13368 | 0.306999 | 0.79 | 1.1e-02 | Click! |
chr10_8127345_8127496 | GATA3 | 30651 | 0.254050 | -0.77 | 1.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_68107852_68108775 | 4.27 |
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
10934 |
0.1 |
chr1_2078854_2079005 | 3.71 |
RP5-892K4.1 |
|
2211 |
0.21 |
chr11_121351250_121351763 | 3.24 |
RP11-730K11.1 |
|
27784 |
0.21 |
chr14_92334861_92335281 | 3.18 |
TC2N |
tandem C2 domains, nuclear |
1198 |
0.5 |
chr20_43996117_43996734 | 3.13 |
SYS1 |
SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae) |
4331 |
0.13 |
chr20_57723964_57724434 | 3.12 |
ZNF831 |
zinc finger protein 831 |
41876 |
0.16 |
chrX_128913033_128913442 | 3.10 |
SASH3 |
SAM and SH3 domain containing 3 |
723 |
0.69 |
chr11_118762748_118763140 | 3.04 |
RP11-158I9.5 |
|
4493 |
0.11 |
chr14_98689187_98689819 | 3.01 |
ENSG00000222066 |
. |
108584 |
0.07 |
chr10_89820679_89820830 | 2.83 |
ENSG00000200891 |
. |
66302 |
0.13 |
chr1_206747367_206748212 | 2.56 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
17296 |
0.15 |
chr19_42380978_42381662 | 2.55 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
30 |
0.96 |
chr16_3123541_3123818 | 2.52 |
ENSG00000252561 |
. |
4155 |
0.07 |
chr15_70007265_70007861 | 2.46 |
ENSG00000238870 |
. |
15598 |
0.26 |
chr3_46017069_46017657 | 2.46 |
FYCO1 |
FYVE and coiled-coil domain containing 1 |
9124 |
0.18 |
chrX_128922282_128922803 | 2.45 |
SASH3 |
SAM and SH3 domain containing 3 |
8582 |
0.19 |
chr1_27156953_27157104 | 2.44 |
ZDHHC18 |
zinc finger, DHHC-type containing 18 |
1467 |
0.28 |
chr17_46514062_46514320 | 2.43 |
SKAP1 |
src kinase associated phosphoprotein 1 |
6610 |
0.15 |
chr11_47417148_47417745 | 2.43 |
RP11-750H9.5 |
|
255 |
0.83 |
chr7_55535980_55536327 | 2.40 |
VOPP1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
47617 |
0.16 |
chr20_1644883_1645856 | 2.39 |
ENSG00000242348 |
. |
1637 |
0.31 |
chr16_68104783_68105066 | 2.37 |
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
14323 |
0.09 |
chr16_3123842_3124007 | 2.30 |
ENSG00000252561 |
. |
4400 |
0.07 |
chr22_40511868_40512134 | 2.30 |
TNRC6B |
trinucleotide repeat containing 6B |
61928 |
0.11 |
chr16_28149944_28150165 | 2.29 |
XPO6 |
exportin 6 |
26843 |
0.16 |
chrX_48771847_48772324 | 2.29 |
PIM2 |
pim-2 oncogene |
927 |
0.37 |
chr22_40315545_40315849 | 2.27 |
GRAP2 |
GRB2-related adaptor protein 2 |
6898 |
0.18 |
chr10_17469337_17469935 | 2.25 |
ST8SIA6-AS1 |
ST8SIA6 antisense RNA 1 |
19610 |
0.17 |
chr14_50563249_50563678 | 2.24 |
C14orf183 |
chromosome 14 open reading frame 183 |
4102 |
0.18 |
chr20_4795714_4796665 | 2.23 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
420 |
0.85 |
chr11_67212387_67212841 | 2.21 |
CORO1B |
coronin, actin binding protein, 1B |
1351 |
0.18 |
chr4_40230061_40230375 | 2.20 |
RHOH |
ras homolog family member H |
28254 |
0.18 |
chr5_133425812_133426164 | 2.19 |
TCF7 |
transcription factor 7 (T-cell specific, HMG-box) |
24414 |
0.2 |
chr6_137674077_137674372 | 2.18 |
IFNGR1 |
interferon gamma receptor 1 |
133638 |
0.05 |
chr9_36145556_36145707 | 2.16 |
GLIPR2 |
GLI pathogenesis-related 2 |
8889 |
0.18 |
chr2_7197696_7198047 | 2.15 |
AC019048.1 |
|
20140 |
0.23 |
chr3_46334824_46335290 | 2.14 |
CCR3 |
chemokine (C-C motif) receptor 3 |
28438 |
0.16 |
chr9_117136205_117136760 | 2.13 |
AKNA |
AT-hook transcription factor |
2762 |
0.28 |
chr6_42358903_42359338 | 2.13 |
ENSG00000221252 |
. |
21014 |
0.2 |
chr3_152023320_152023535 | 2.12 |
MBNL1 |
muscleblind-like splicing regulator 1 |
5440 |
0.24 |
chr1_26873022_26873700 | 2.09 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
1018 |
0.45 |
chr11_6424420_6425308 | 2.09 |
APBB1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
1030 |
0.44 |
chr14_98173448_98173821 | 2.08 |
RP11-204N11.1 |
Uncharacterized protein |
55534 |
0.17 |
chr15_85264382_85264668 | 2.08 |
SEC11A |
SEC11 homolog A (S. cerevisiae) |
4578 |
0.15 |
chr11_121351922_121352170 | 2.08 |
RP11-730K11.1 |
|
28324 |
0.21 |
chr5_169703034_169703822 | 2.07 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
9097 |
0.23 |
chr1_167471488_167471706 | 2.06 |
CD247 |
CD247 molecule |
16178 |
0.19 |
chr16_79652368_79652707 | 2.06 |
MAF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
17926 |
0.26 |
chr16_71914316_71914975 | 2.05 |
ZNF821 |
zinc finger protein 821 |
677 |
0.52 |
chr5_150597516_150598012 | 2.05 |
CCDC69 |
coiled-coil domain containing 69 |
5942 |
0.19 |
chr10_126414122_126414344 | 2.05 |
FAM53B |
family with sequence similarity 53, member B |
17306 |
0.16 |
chr10_11274678_11275059 | 2.04 |
RP3-323N1.2 |
|
61529 |
0.12 |
chr22_23165498_23166442 | 2.04 |
ENSG00000207836 |
. |
700 |
0.26 |
chrX_1583335_1583708 | 2.02 |
ASMTL |
acetylserotonin O-methyltransferase-like |
10866 |
0.19 |
chr7_50416211_50416637 | 2.02 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
49179 |
0.16 |
chr11_128173540_128173801 | 2.02 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
201619 |
0.03 |
chr10_73512178_73512989 | 2.01 |
C10orf54 |
chromosome 10 open reading frame 54 |
4804 |
0.22 |
chr7_100147991_100148484 | 2.00 |
AGFG2 |
ArfGAP with FG repeats 2 |
5053 |
0.1 |
chr1_6524239_6524483 | 2.00 |
TNFRSF25 |
tumor necrosis factor receptor superfamily, member 25 |
1329 |
0.29 |
chr1_92013670_92014119 | 1.99 |
CDC7 |
cell division cycle 7 |
47199 |
0.19 |
chr1_155939676_155940356 | 1.98 |
ARHGEF2 |
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
496 |
0.63 |
chr8_19554391_19555213 | 1.98 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
14530 |
0.29 |
chr4_40239093_40239470 | 1.97 |
RHOH |
ras homolog family member H |
37317 |
0.16 |
chr8_142413099_142413596 | 1.97 |
CTD-3064M3.4 |
|
10673 |
0.12 |
chr8_37124457_37124916 | 1.96 |
RP11-150O12.6 |
|
249853 |
0.02 |
chrX_134517228_134517850 | 1.96 |
ZNF449 |
zinc finger protein 449 |
38818 |
0.14 |
chr16_15730549_15730942 | 1.96 |
KIAA0430 |
KIAA0430 |
5600 |
0.14 |
chr15_60850340_60850622 | 1.95 |
CTD-2501E16.2 |
|
28309 |
0.16 |
chr6_41169630_41170026 | 1.93 |
TREML2 |
triggering receptor expressed on myeloid cells-like 2 |
896 |
0.47 |
chr14_98658043_98658325 | 1.93 |
ENSG00000222066 |
. |
139903 |
0.05 |
chr11_13944271_13944534 | 1.93 |
ENSG00000201856 |
. |
15265 |
0.29 |
chr1_151025492_151025717 | 1.93 |
MLLT11 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11 |
4630 |
0.09 |
chr14_78224263_78224414 | 1.92 |
C14orf178 |
chromosome 14 open reading frame 178 |
2835 |
0.18 |
chr3_67789239_67789462 | 1.91 |
SUCLG2 |
succinate-CoA ligase, GDP-forming, beta subunit |
84312 |
0.1 |
chr17_8856804_8857368 | 1.91 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
11938 |
0.24 |
chr7_149565914_149566574 | 1.90 |
ATP6V0E2 |
ATPase, H+ transporting V0 subunit e2 |
3813 |
0.19 |
chr18_21589322_21589666 | 1.89 |
TTC39C |
tetratricopeptide repeat domain 39C |
4890 |
0.2 |
chr21_32736711_32737011 | 1.89 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
20267 |
0.27 |
chr6_35278431_35279308 | 1.89 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
1354 |
0.42 |
chr13_74288455_74288993 | 1.88 |
KLF12 |
Kruppel-like factor 12 |
280462 |
0.01 |
chr17_80406015_80406483 | 1.87 |
C17orf62 |
chromosome 17 open reading frame 62 |
1232 |
0.26 |
chr20_1642138_1642418 | 1.87 |
SIRPG |
signal-regulatory protein gamma |
3853 |
0.18 |
chr4_90218630_90219104 | 1.87 |
GPRIN3 |
GPRIN family member 3 |
10294 |
0.3 |
chr12_68025335_68025706 | 1.86 |
DYRK2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
16598 |
0.25 |
chr12_57872327_57873305 | 1.86 |
ARHGAP9 |
Rho GTPase activating protein 9 |
423 |
0.65 |
chr1_206725511_206725875 | 1.86 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
4800 |
0.19 |
chr11_114086673_114087539 | 1.86 |
NNMT |
nicotinamide N-methyltransferase |
41447 |
0.17 |
chr22_20846545_20846877 | 1.85 |
KLHL22 |
kelch-like family member 22 |
867 |
0.4 |
chr2_202135550_202135981 | 1.85 |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
1596 |
0.39 |
chr10_35748075_35748226 | 1.83 |
CCNY |
cyclin Y |
122348 |
0.05 |
chrX_17788277_17788428 | 1.83 |
SCML1 |
sex comb on midleg-like 1 (Drosophila) |
32507 |
0.21 |
chr19_30170651_30170950 | 1.83 |
PLEKHF1 |
pleckstrin homology domain containing, family F (with FYVE domain) member 1 |
13019 |
0.22 |
chr17_17086981_17087260 | 1.82 |
RP11-45M22.3 |
|
1748 |
0.23 |
chr17_78845626_78846398 | 1.82 |
RPTOR |
regulatory associated protein of MTOR, complex 1 |
50512 |
0.1 |
chr1_227953301_227953602 | 1.82 |
SNAP47 |
synaptosomal-associated protein, 47kDa |
17687 |
0.15 |
chr1_154986722_154986873 | 1.82 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
127 |
0.9 |
chr3_14471941_14472448 | 1.81 |
SLC6A6 |
solute carrier family 6 (neurotransmitter transporter), member 6 |
1984 |
0.39 |
chr1_206752443_206752919 | 1.81 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
22188 |
0.14 |
chr12_113645600_113646083 | 1.80 |
IQCD |
IQ motif containing D |
12991 |
0.1 |
chr3_107697956_107698544 | 1.80 |
CD47 |
CD47 molecule |
78958 |
0.11 |
chr6_133083669_133083932 | 1.79 |
VNN2 |
vanin 2 |
770 |
0.53 |
chr1_26697390_26697759 | 1.79 |
ZNF683 |
zinc finger protein 683 |
333 |
0.82 |
chr11_13317095_13317246 | 1.79 |
ARNTL |
aryl hydrocarbon receptor nuclear translocator-like |
14363 |
0.25 |
chr17_66292298_66292929 | 1.78 |
ARSG |
arylsulfatase G |
4954 |
0.19 |
chr21_43843966_43844673 | 1.77 |
ENSG00000252619 |
. |
6617 |
0.14 |
chr10_63868726_63869208 | 1.77 |
ENSG00000221094 |
. |
7007 |
0.28 |
chr2_3299611_3299762 | 1.77 |
TSSC1-IT1 |
TSSC1 intronic transcript 1 (non-protein coding) |
5550 |
0.27 |
chr14_23013063_23013415 | 1.76 |
AE000662.92 |
Uncharacterized protein |
12295 |
0.1 |
chr3_113950179_113950372 | 1.76 |
ZNF80 |
zinc finger protein 80 |
6150 |
0.18 |
chr9_95731994_95732145 | 1.75 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
4695 |
0.25 |
chr14_97429802_97430107 | 1.75 |
VRK1 |
vaccinia related kinase 1 |
87588 |
0.1 |
chr12_53592478_53593243 | 1.75 |
ITGB7 |
integrin, beta 7 |
1367 |
0.28 |
chr12_50064173_50064541 | 1.74 |
FMNL3 |
formin-like 3 |
36646 |
0.11 |
chr11_121320555_121321108 | 1.74 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
2081 |
0.35 |
chr1_160596572_160596895 | 1.74 |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
20078 |
0.14 |
chr2_86081314_86081925 | 1.74 |
ST3GAL5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
13158 |
0.17 |
chr16_30486446_30487024 | 1.74 |
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
1413 |
0.16 |
chr3_48519266_48519585 | 1.73 |
SHISA5 |
shisa family member 5 |
4808 |
0.1 |
chr11_6742431_6742729 | 1.73 |
GVINP1 |
GTPase, very large interferon inducible pseudogene 1 |
531 |
0.69 |
chr9_92137624_92138172 | 1.73 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
24853 |
0.2 |
chr18_29622386_29622822 | 1.72 |
ENSG00000265063 |
. |
18348 |
0.13 |
chr1_154310385_154310827 | 1.72 |
ENSG00000238365 |
. |
613 |
0.57 |
chr5_169718481_169718670 | 1.72 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
6656 |
0.24 |
chr1_161036793_161037056 | 1.71 |
AL591806.1 |
Uncharacterized protein |
1269 |
0.22 |
chr19_58011042_58011193 | 1.71 |
ZNF773 |
zinc finger protein 773 |
166 |
0.9 |
chr1_167407962_167408153 | 1.71 |
RP11-104L21.2 |
|
19841 |
0.19 |
chr1_26648398_26648663 | 1.70 |
UBXN11 |
UBX domain protein 11 |
3676 |
0.13 |
chr7_130772886_130773250 | 1.70 |
LINC-PINT |
long intergenic non-protein coding RNA, p53 induced transcript |
165 |
0.96 |
chr19_16486771_16487116 | 1.70 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
14179 |
0.14 |
chr11_7549352_7549503 | 1.69 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
10081 |
0.18 |
chr12_124940682_124941070 | 1.69 |
NCOR2 |
nuclear receptor corepressor 2 |
27439 |
0.25 |
chr14_91855068_91855898 | 1.69 |
CCDC88C |
coiled-coil domain containing 88C |
28207 |
0.19 |
chr17_72740189_72740398 | 1.69 |
ENSG00000264624 |
. |
4459 |
0.11 |
chr2_113940950_113941232 | 1.69 |
AC016683.5 |
|
8154 |
0.14 |
chr2_192604252_192604657 | 1.68 |
AC098872.3 |
|
53697 |
0.14 |
chr9_126965413_126965631 | 1.68 |
NEK6 |
NIMA-related kinase 6 |
54363 |
0.12 |
chr20_42640204_42640377 | 1.68 |
ENSG00000241229 |
. |
4402 |
0.27 |
chr10_29969321_29969583 | 1.68 |
ENSG00000222092 |
. |
31392 |
0.18 |
chr7_50422851_50423205 | 1.68 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
55783 |
0.14 |
chr11_118797773_118797990 | 1.68 |
ENSG00000239726 |
. |
4039 |
0.1 |
chr1_168490081_168490873 | 1.68 |
XCL2 |
chemokine (C motif) ligand 2 |
22758 |
0.22 |
chr17_2700875_2701302 | 1.68 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
1312 |
0.43 |
chr19_18655304_18655455 | 1.68 |
FKBP8 |
FK506 binding protein 8, 38kDa |
492 |
0.6 |
chr2_106383100_106383458 | 1.68 |
NCK2 |
NCK adaptor protein 2 |
21091 |
0.26 |
chrY_1533200_1533719 | 1.67 |
NA |
NA |
> 106 |
NA |
chr14_66394986_66395728 | 1.67 |
CTD-2014B16.3 |
Uncharacterized protein |
75884 |
0.11 |
chr5_36934517_36934776 | 1.67 |
NIPBL |
Nipped-B homolog (Drosophila) |
57754 |
0.16 |
chr17_47824865_47825302 | 1.66 |
FAM117A |
family with sequence similarity 117, member A |
16410 |
0.14 |
chr17_74654348_74654842 | 1.66 |
ENSG00000199735 |
. |
2193 |
0.16 |
chr14_105528334_105528780 | 1.66 |
GPR132 |
G protein-coupled receptor 132 |
3210 |
0.24 |
chr1_160588791_160589127 | 1.65 |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
27852 |
0.12 |
chr11_73086432_73086886 | 1.65 |
RELT |
RELT tumor necrosis factor receptor |
650 |
0.64 |
chr22_25463288_25463449 | 1.65 |
KIAA1671 |
KIAA1671 |
2568 |
0.34 |
chr5_692324_692475 | 1.65 |
TPPP |
tubulin polymerization promoting protein |
1111 |
0.45 |
chrX_70324332_70324541 | 1.64 |
CXorf65 |
chromosome X open reading frame 65 |
2019 |
0.18 |
chr19_16486076_16486459 | 1.64 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
13503 |
0.14 |
chr6_144789262_144789433 | 1.64 |
UTRN |
utrophin |
114999 |
0.07 |
chr14_91790763_91791635 | 1.64 |
ENSG00000265856 |
. |
8858 |
0.21 |
chr14_98656916_98657071 | 1.63 |
ENSG00000222066 |
. |
141094 |
0.05 |
chr8_11315691_11316123 | 1.63 |
FAM167A |
family with sequence similarity 167, member A |
8369 |
0.15 |
chr10_26759653_26759911 | 1.63 |
APBB1IP |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
32428 |
0.2 |
chr1_160644246_160644601 | 1.63 |
RP11-404F10.2 |
|
1111 |
0.45 |
chr8_125575470_125576116 | 1.62 |
MTSS1 |
metastasis suppressor 1 |
2175 |
0.26 |
chr6_45554984_45555365 | 1.62 |
ENSG00000252738 |
. |
58667 |
0.16 |
chr16_3266168_3266379 | 1.62 |
OR1F1 |
olfactory receptor, family 1, subfamily F, member 1 |
12026 |
0.09 |
chr15_31624599_31624851 | 1.62 |
KLF13 |
Kruppel-like factor 13 |
5667 |
0.32 |
chr6_42333639_42334140 | 1.62 |
ENSG00000221252 |
. |
46245 |
0.14 |
chr2_85092189_85092490 | 1.61 |
TRABD2A |
TraB domain containing 2A |
15867 |
0.19 |
chr6_108048768_108049144 | 1.61 |
SCML4 |
sex comb on midleg-like 4 (Drosophila) |
4643 |
0.33 |
chr15_91851085_91851631 | 1.61 |
SV2B |
synaptic vesicle glycoprotein 2B |
82258 |
0.1 |
chr10_89826192_89826568 | 1.60 |
ENSG00000200891 |
. |
71928 |
0.12 |
chr17_61780107_61780446 | 1.60 |
STRADA |
STE20-related kinase adaptor alpha |
1539 |
0.28 |
chr8_126658824_126659129 | 1.60 |
ENSG00000266452 |
. |
202169 |
0.03 |
chr12_7067345_7067996 | 1.60 |
ENSG00000207713 |
. |
5192 |
0.06 |
chr9_92151633_92152777 | 1.59 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
39160 |
0.16 |
chr22_50183219_50183629 | 1.59 |
BRD1 |
bromodomain containing 1 |
33429 |
0.15 |
chr14_52378888_52379324 | 1.59 |
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2 |
724 |
0.64 |
chr2_102983409_102983883 | 1.59 |
IL18R1 |
interleukin 18 receptor 1 |
4525 |
0.2 |
chr19_46294986_46295331 | 1.59 |
DMWD |
dystrophia myotonica, WD repeat containing |
537 |
0.56 |
chr3_49453158_49453470 | 1.58 |
TCTA |
T-cell leukemia translocation altered |
3675 |
0.11 |
chr17_72459036_72459537 | 1.58 |
CD300A |
CD300a molecule |
3269 |
0.19 |
chr1_111738933_111739395 | 1.58 |
DENND2D |
DENN/MADD domain containing 2D |
4147 |
0.14 |
chr10_12408648_12409146 | 1.58 |
CAMK1D |
calcium/calmodulin-dependent protein kinase ID |
17165 |
0.17 |
chr3_46007058_46007478 | 1.58 |
FYCO1 |
FYVE and coiled-coil domain containing 1 |
7115 |
0.18 |
chr14_98676295_98676520 | 1.58 |
ENSG00000222066 |
. |
121680 |
0.06 |
chr7_149562206_149562836 | 1.57 |
RP4-751H13.7 |
|
2940 |
0.22 |
chr2_42331828_42332250 | 1.57 |
PKDCC |
protein kinase domain containing, cytoplasmic |
56879 |
0.12 |
chr8_118456065_118456216 | 1.56 |
MED30 |
mediator complex subunit 30 |
76812 |
0.12 |
chr13_46752398_46752790 | 1.56 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
3865 |
0.19 |
chr15_60879874_60880268 | 1.55 |
RORA |
RAR-related orphan receptor A |
4669 |
0.26 |
chr2_231088587_231088821 | 1.55 |
SP110 |
SP110 nuclear body protein |
1740 |
0.3 |
chr5_98269675_98269959 | 1.55 |
ENSG00000200351 |
. |
2634 |
0.3 |
chr2_3299852_3300003 | 1.55 |
TSSC1-IT1 |
TSSC1 intronic transcript 1 (non-protein coding) |
5309 |
0.28 |
chr10_22996678_22996829 | 1.55 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
6284 |
0.3 |
chrX_49135309_49135460 | 1.55 |
PPP1R3F |
protein phosphatase 1, regulatory subunit 3F |
1855 |
0.18 |
chr3_171211880_171212204 | 1.55 |
ENSG00000207114 |
. |
10098 |
0.23 |
chr18_43268903_43269487 | 1.55 |
SLC14A2 |
solute carrier family 14 (urea transporter), member 2 |
23088 |
0.16 |
chr2_231186507_231186774 | 1.54 |
SP140L |
SP140 nuclear body protein-like |
5259 |
0.27 |
chr15_38979216_38979456 | 1.54 |
C15orf53 |
chromosome 15 open reading frame 53 |
9463 |
0.29 |
chr11_117870973_117871190 | 1.54 |
IL10RA |
interleukin 10 receptor, alpha |
13972 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
3.0 | 12.1 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
2.8 | 11.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
2.7 | 2.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
2.7 | 8.2 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
2.6 | 7.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
2.6 | 7.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
2.4 | 9.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
2.3 | 18.6 | GO:0007172 | signal complex assembly(GO:0007172) |
2.3 | 9.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.2 | 2.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
2.1 | 6.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.0 | 5.9 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
2.0 | 9.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.9 | 3.9 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
1.9 | 5.7 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
1.8 | 5.5 | GO:0043368 | positive T cell selection(GO:0043368) |
1.7 | 3.3 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
1.6 | 24.3 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
1.6 | 1.6 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
1.6 | 4.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.6 | 1.6 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
1.5 | 3.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.5 | 4.6 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
1.5 | 12.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.5 | 3.0 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
1.4 | 4.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.4 | 7.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
1.4 | 4.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.4 | 6.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.4 | 36.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
1.4 | 4.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
1.3 | 2.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.3 | 3.9 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
1.2 | 3.7 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
1.2 | 2.4 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
1.2 | 6.1 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
1.2 | 1.2 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.2 | 3.6 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
1.2 | 3.5 | GO:0097300 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
1.2 | 5.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.1 | 5.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.1 | 1.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
1.1 | 2.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
1.1 | 9.0 | GO:0006491 | N-glycan processing(GO:0006491) |
1.1 | 8.9 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
1.1 | 1.1 | GO:0001866 | NK T cell proliferation(GO:0001866) NK T cell activation(GO:0051132) |
1.1 | 4.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
1.1 | 4.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.0 | 1.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.0 | 1.0 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
1.0 | 1.0 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
1.0 | 3.0 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
1.0 | 3.9 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
1.0 | 1.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.0 | 1.0 | GO:0033622 | integrin activation(GO:0033622) |
1.0 | 1.9 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
1.0 | 1.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.9 | 2.8 | GO:0010447 | response to acidic pH(GO:0010447) |
0.9 | 60.7 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.9 | 7.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.9 | 3.7 | GO:2000649 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.9 | 1.8 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.9 | 2.7 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.9 | 2.7 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.9 | 2.7 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.9 | 2.7 | GO:0002507 | tolerance induction(GO:0002507) |
0.9 | 4.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.9 | 6.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.9 | 9.6 | GO:0030260 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.9 | 1.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.9 | 1.7 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.8 | 1.7 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.8 | 0.8 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.8 | 2.5 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.8 | 2.5 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.8 | 16.5 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.8 | 3.3 | GO:0002836 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.8 | 2.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.8 | 1.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.8 | 2.5 | GO:0045056 | transcytosis(GO:0045056) |
0.8 | 4.1 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.8 | 4.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.8 | 2.4 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.8 | 3.2 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.8 | 7.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.8 | 2.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.8 | 0.8 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.8 | 7.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.8 | 2.3 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.8 | 3.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.8 | 2.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.8 | 3.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.7 | 3.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.7 | 1.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.7 | 0.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.7 | 2.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.7 | 2.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.7 | 0.7 | GO:0017085 | response to insecticide(GO:0017085) |
0.7 | 3.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.7 | 2.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.7 | 8.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.7 | 0.7 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.7 | 0.7 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.7 | 0.7 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.7 | 0.7 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.7 | 2.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.7 | 7.4 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.7 | 3.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.7 | 2.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.7 | 2.6 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.7 | 1.3 | GO:0071503 | response to heparin(GO:0071503) |
0.6 | 0.6 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.6 | 1.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.6 | 0.6 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.6 | 0.6 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.6 | 1.3 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.6 | 4.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.6 | 1.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.6 | 2.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.6 | 6.8 | GO:0000303 | response to superoxide(GO:0000303) |
0.6 | 0.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.6 | 1.8 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.6 | 3.6 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.6 | 2.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.6 | 3.0 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.6 | 1.2 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.6 | 1.8 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 | 4.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.6 | 0.6 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.6 | 1.7 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.6 | 8.0 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.6 | 1.7 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.6 | 0.6 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.6 | 2.3 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.6 | 2.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.6 | 1.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.6 | 2.8 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.6 | 1.7 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.6 | 2.2 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.6 | 1.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.6 | 14.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.6 | 1.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 1.1 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.6 | 1.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.6 | 0.6 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.6 | 3.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.6 | 1.1 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 0.6 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.5 | 1.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.5 | 0.5 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.5 | 1.6 | GO:0032506 | cytokinetic process(GO:0032506) |
0.5 | 2.2 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.5 | 2.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 1.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 1.6 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.5 | 2.7 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.5 | 0.5 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.5 | 1.0 | GO:0001821 | histamine secretion(GO:0001821) |
0.5 | 1.6 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.5 | 16.6 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.5 | 7.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 1.5 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.5 | 1.0 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.5 | 3.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 2.5 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.5 | 1.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.5 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.5 | 0.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.5 | 0.5 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.5 | 1.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.5 | 2.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.5 | 1.0 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.5 | 3.9 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.5 | 1.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.5 | 0.5 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.5 | 2.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.5 | 3.4 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.5 | 1.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.5 | 0.5 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.5 | 1.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.5 | 1.9 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.5 | 1.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.5 | 2.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.5 | 3.3 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.5 | 2.4 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.5 | 0.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.5 | 10.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.5 | 1.9 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.5 | 1.4 | GO:0098801 | regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
0.5 | 1.8 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.5 | 6.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.5 | 1.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.5 | 0.5 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.4 | 1.8 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 0.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.4 | 1.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 3.5 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.4 | 2.2 | GO:0097581 | lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
0.4 | 6.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.4 | 1.3 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.4 | 5.6 | GO:0045730 | respiratory burst(GO:0045730) |
0.4 | 1.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 0.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.4 | 3.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.4 | 5.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.4 | 0.4 | GO:2001259 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) positive regulation of calcium ion transmembrane transporter activity(GO:1901021) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) positive regulation of cation channel activity(GO:2001259) |
0.4 | 2.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 1.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 1.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 1.7 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.4 | 1.7 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.4 | 0.8 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 | 2.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.4 | 3.7 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.4 | 1.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 1.2 | GO:0007140 | male meiosis(GO:0007140) |
0.4 | 0.4 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.4 | 2.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.4 | 1.2 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.4 | 1.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.4 | 1.6 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.4 | 2.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.4 | 3.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 1.6 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.4 | 1.6 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 0.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 1.2 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 1.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 0.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.4 | 3.1 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.4 | 2.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 1.5 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.4 | 6.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.4 | 1.5 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.4 | 0.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 2.3 | GO:1902115 | regulation of organelle assembly(GO:1902115) |
0.4 | 1.5 | GO:0003407 | neural retina development(GO:0003407) |
0.4 | 0.8 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.4 | 0.8 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.4 | 6.8 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.4 | 2.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.4 | 1.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 0.7 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.4 | 0.7 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.4 | 0.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.4 | 1.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.4 | 0.4 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.4 | 0.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.4 | 1.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.4 | 0.7 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.4 | 1.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 0.7 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.4 | 2.9 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.4 | 0.4 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.4 | 3.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.4 | 13.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 1.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.4 | 0.4 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.4 | 0.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.4 | 2.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.4 | 2.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 1.4 | GO:0001832 | blastocyst growth(GO:0001832) |
0.4 | 1.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.4 | 1.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 0.7 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 0.4 | GO:0070245 | positive regulation of T cell apoptotic process(GO:0070234) positive regulation of thymocyte apoptotic process(GO:0070245) |
0.4 | 0.4 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.4 | 1.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 1.8 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.4 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 1.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.4 | 2.1 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.3 | 2.4 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.3 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.3 | 1.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.3 | 1.4 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.3 | 5.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.3 | 0.3 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.3 | 1.0 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.3 | 2.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 2.0 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.3 | 2.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 2.3 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.3 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.3 | 2.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 1.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 0.6 | GO:0060744 | thelarche(GO:0042695) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 1.3 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.3 | 1.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.3 | 0.3 | GO:1902622 | regulation of granulocyte chemotaxis(GO:0071622) regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.3 | 0.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.3 | 0.3 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.3 | 0.3 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 5.3 | GO:0016236 | macroautophagy(GO:0016236) |
0.3 | 0.6 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 0.3 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.3 | 1.5 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 4.3 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.3 | 4.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.3 | 0.9 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.3 | 0.3 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.3 | 0.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 1.2 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.3 | 4.6 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.3 | 0.6 | GO:0090399 | replicative senescence(GO:0090399) |
0.3 | 0.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.3 | 2.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.3 | 23.7 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 0.9 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.3 | 0.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 0.6 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.3 | 4.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 1.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.3 | 0.3 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.3 | 1.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 0.9 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 1.5 | GO:1901998 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.3 | 1.8 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.3 | 0.9 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.3 | 0.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.3 | 0.9 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.3 | 2.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 4.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.3 | 0.6 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.3 | 1.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 4.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.3 | 4.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.3 | 1.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.3 | 0.6 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.3 | 1.4 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.3 | 0.9 | GO:0031034 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 0.3 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.3 | 6.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 14.1 | GO:0007498 | mesoderm development(GO:0007498) |
0.3 | 1.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 0.3 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.3 | 0.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 1.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.3 | 0.6 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.3 | 1.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 0.3 | GO:0021940 | ventral midline development(GO:0007418) regulation of cerebellar granule cell precursor proliferation(GO:0021936) cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.3 | 0.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 0.3 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.3 | 2.2 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.3 | 0.3 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.3 | 0.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.3 | 4.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.3 | 1.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 2.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.8 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) positive regulation of tooth mineralization(GO:0070172) |
0.3 | 0.5 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.3 | 0.8 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.3 | 0.8 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.3 | 3.0 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.3 | 1.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 1.6 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 0.8 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.3 | 7.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.3 | 1.6 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.3 | 1.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 12.5 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.3 | 2.3 | GO:0014823 | response to activity(GO:0014823) |
0.3 | 1.6 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.3 | 0.3 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.3 | 0.3 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.3 | 0.3 | GO:0051446 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.3 | 0.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 0.8 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.3 | 1.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 0.8 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 1.0 | GO:0042117 | monocyte activation(GO:0042117) |
0.3 | 1.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 3.0 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.3 | 4.6 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.3 | 0.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 1.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 0.8 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.2 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.2 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.2 | 0.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 0.5 | GO:0098754 | detoxification(GO:0098754) |
0.2 | 1.0 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.2 | 2.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 2.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 3.9 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.5 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.2 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.2 | 1.2 | GO:0001906 | cell killing(GO:0001906) |
0.2 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.7 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.2 | 1.9 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.2 | 2.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 2.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.2 | 0.7 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.2 | 12.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.2 | 0.2 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.2 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 0.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.9 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 0.5 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.2 | 1.9 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.9 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.2 | 0.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.5 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.2 | 0.7 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.2 | 0.5 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.2 | 0.7 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.2 | 1.1 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.2 | 0.2 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.2 | 0.2 | GO:0071514 | genetic imprinting(GO:0071514) |
0.2 | 0.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.5 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 0.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.7 | GO:0033032 | regulation of myeloid cell apoptotic process(GO:0033032) |
0.2 | 0.2 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 0.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 4.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.2 | 1.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 0.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.4 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
0.2 | 0.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.4 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.2 | 1.5 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.2 | 0.9 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.2 | 0.7 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.2 | GO:0072074 | kidney mesenchyme development(GO:0072074) metanephric mesenchyme development(GO:0072075) |
0.2 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.7 | GO:0033483 | gas homeostasis(GO:0033483) |
0.2 | 2.4 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.2 | 0.7 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.2 | 0.2 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.2 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.6 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 1.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.4 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.2 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.9 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 10.4 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.2 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.9 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.2 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.2 | 0.4 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.2 | 0.2 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.2 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.8 | GO:0015851 | nucleobase transport(GO:0015851) |
0.2 | 2.5 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.2 | 0.2 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.2 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.6 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 1.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 2.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.6 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.2 | 1.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.2 | 0.4 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.2 | 0.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.2 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.2 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.0 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.2 | 1.0 | GO:0006302 | double-strand break repair(GO:0006302) |
0.2 | 3.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.6 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.2 | 1.0 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 0.8 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.2 | 0.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 1.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.2 | 0.4 | GO:0090398 | cellular senescence(GO:0090398) |
0.2 | 0.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 1.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 1.4 | GO:0042596 | fear response(GO:0042596) |
0.2 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 3.7 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.2 | 2.1 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.2 | 0.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 1.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 3.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 0.2 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.2 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 1.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 0.4 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.2 | 0.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.7 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.2 | 0.9 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.9 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.2 | 0.2 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 1.7 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.2 | 1.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 3.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 0.5 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.2 | 0.4 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 0.2 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 0.2 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.2 | 0.2 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.2 | 0.4 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.2 | 1.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.2 | 1.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 2.4 | GO:0051607 | defense response to virus(GO:0051607) |
0.2 | 0.7 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 0.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 2.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.5 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.2 | 0.2 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.2 | 0.5 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.2 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.2 | 0.2 | GO:0060013 | righting reflex(GO:0060013) |
0.2 | 1.9 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.2 | 0.7 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.2 | 0.5 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.2 | 2.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.3 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.2 | 1.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.2 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
0.2 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.2 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.2 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.3 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 1.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.2 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 1.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 0.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 0.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.2 | 1.0 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.2 | 0.7 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.2 | 1.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 1.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 1.9 | GO:0048255 | RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
0.2 | 0.8 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 1.0 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.2 | 2.7 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 0.3 | GO:0001510 | RNA methylation(GO:0001510) |
0.2 | 1.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.6 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.5 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.2 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.2 | 0.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 0.5 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 37.4 | GO:0006397 | mRNA processing(GO:0006397) |
0.2 | 1.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.2 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.2 | 0.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 0.9 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.2 | 1.7 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 0.3 | GO:1903556 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.2 | 0.3 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 1.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 4.3 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 10.1 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 1.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.6 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 2.2 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 1.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.3 | GO:0072234 | metanephric nephron tubule development(GO:0072234) metanephric nephron epithelium development(GO:0072243) |
0.1 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.1 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.1 | 2.5 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.6 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 1.0 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.4 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.7 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.1 | 1.2 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.3 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.9 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 3.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 2.0 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.1 | 1.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 1.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.4 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.3 | GO:0014904 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 1.0 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 1.1 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.8 | GO:0001947 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.1 | 1.0 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.1 | 1.0 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.7 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 0.3 | GO:0055067 | monovalent inorganic cation homeostasis(GO:0055067) |
0.1 | 1.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 1.4 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 4.7 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 1.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.3 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.5 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 1.9 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.3 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.3 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 0.4 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.5 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.8 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.8 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 1.9 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.8 | GO:0051324 | prophase(GO:0051324) |
0.1 | 0.8 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.8 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.9 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.4 | GO:0043049 | otic placode formation(GO:0043049) |
0.1 | 1.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.8 | GO:1901071 | N-acetylglucosamine metabolic process(GO:0006044) glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 0.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.4 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 1.0 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 12.4 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.6 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.5 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.7 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.5 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.2 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 5.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.5 | GO:0032273 | positive regulation of protein polymerization(GO:0032273) |
0.1 | 0.5 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.1 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.1 | 2.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.1 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 0.1 | GO:0034121 | regulation of toll-like receptor signaling pathway(GO:0034121) positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.1 | 0.2 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.1 | 0.2 | GO:0061462 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 0.1 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) regulation of thymocyte apoptotic process(GO:0070243) |
0.1 | 5.9 | GO:0045087 | innate immune response(GO:0045087) |
0.1 | 0.1 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 1.6 | GO:0006885 | regulation of pH(GO:0006885) |
0.1 | 1.2 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.1 | 1.8 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.2 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.5 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.1 | 0.3 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.6 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.1 | 5.1 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 4.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.6 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) telomere formation via telomerase(GO:0032203) |
0.1 | 0.1 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.1 | 0.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 8.7 | GO:0050776 | regulation of immune response(GO:0050776) |
0.1 | 1.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 2.4 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.1 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 3.0 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.1 | 0.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.2 | GO:0043574 | peroxisomal transport(GO:0043574) |
0.1 | 1.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 1.0 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.1 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 1.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.9 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.1 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.1 | 0.5 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.7 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 14.1 | GO:0006955 | immune response(GO:0006955) |
0.1 | 0.7 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.2 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.1 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 3.6 | GO:0070489 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.3 | GO:0030147 | obsolete natriuresis(GO:0030147) |
0.1 | 1.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.4 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.1 | 0.2 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 4.7 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.1 | 0.2 | GO:0060487 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 15.1 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.1 | 1.8 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.7 | GO:0051329 | mitotic interphase(GO:0051329) |
0.1 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.2 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 1.3 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.1 | 0.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.7 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 3.7 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 2.5 | GO:0007281 | germ cell development(GO:0007281) |
0.1 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 1.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.2 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.1 | 1.0 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.1 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.1 | 0.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 2.8 | GO:0009615 | response to virus(GO:0009615) |
0.1 | 0.2 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.2 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 0.3 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 1.3 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.1 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 1.9 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.2 | GO:0018205 | peptidyl-lysine modification(GO:0018205) |
0.1 | 0.1 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 20.6 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.6 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.1 | GO:0022406 | membrane docking(GO:0022406) |
0.1 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.1 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.5 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.1 | GO:0006403 | RNA localization(GO:0006403) |
0.1 | 0.5 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.5 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 1.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.8 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 1.9 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.1 | 0.3 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 1.7 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.1 | 3.8 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.9 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.1 | 0.1 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 0.3 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 5.0 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 2.0 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.1 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.1 | GO:0044340 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.2 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.3 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 1.3 | GO:0009135 | purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) |
0.0 | 0.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 18.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.8 | GO:0046460 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.0 | 0.1 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.0 | 0.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.8 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.0 | 4.2 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.3 | GO:0046386 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) deoxyribose phosphate catabolic process(GO:0046386) |
0.0 | 0.1 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.5 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.3 | GO:0048895 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.0 | 0.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.9 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.3 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.0 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:1900543 | negative regulation of purine nucleotide metabolic process(GO:1900543) |
0.0 | 0.4 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.0 | 0.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.5 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 2.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.0 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.2 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.5 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.0 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.0 | 0.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.0 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.2 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.0 | GO:0021754 | facial nucleus development(GO:0021754) |
0.0 | 0.5 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.1 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.0 | 0.7 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.0 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.0 | 0.0 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.3 | 2.3 | GO:0005921 | gap junction(GO:0005921) |
1.9 | 1.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.4 | 1.4 | GO:0000803 | sex chromosome(GO:0000803) |
1.3 | 10.5 | GO:0001891 | phagocytic cup(GO:0001891) |
1.3 | 3.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.3 | 3.8 | GO:0072487 | MSL complex(GO:0072487) |
1.2 | 3.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.1 | 12.2 | GO:0001772 | immunological synapse(GO:0001772) |
1.0 | 9.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.0 | 6.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.0 | 5.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.0 | 4.0 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.9 | 3.7 | GO:0043218 | compact myelin(GO:0043218) |
0.9 | 2.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.9 | 2.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.9 | 12.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.9 | 3.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.8 | 3.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.8 | 9.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.8 | 2.4 | GO:0032009 | early phagosome(GO:0032009) |
0.8 | 4.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.8 | 4.6 | GO:0005883 | neurofilament(GO:0005883) |
0.8 | 4.6 | GO:0030673 | axolemma(GO:0030673) |
0.8 | 3.8 | GO:0005884 | actin filament(GO:0005884) |
0.7 | 2.2 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.7 | 2.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.7 | 2.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.7 | 1.3 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.7 | 2.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.7 | 4.0 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 1.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.6 | 3.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 5.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.6 | 21.0 | GO:0030175 | filopodium(GO:0030175) |
0.6 | 1.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.6 | 7.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.6 | 8.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.6 | 5.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.6 | 5.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.6 | 3.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.6 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 2.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 1.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.5 | 3.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.5 | 2.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 0.5 | GO:1990204 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) oxidoreductase complex(GO:1990204) |
0.5 | 0.9 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.5 | 2.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 1.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.5 | 2.3 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 13.7 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.4 | 2.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 4.9 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 2.2 | GO:0000791 | euchromatin(GO:0000791) |
0.4 | 3.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.4 | 1.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 1.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 1.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 2.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 1.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 1.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 1.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 4.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.4 | 1.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 2.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.4 | 0.8 | GO:0031312 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of organelle membrane(GO:0031312) extrinsic component of endosome membrane(GO:0031313) |
0.4 | 17.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.4 | 4.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 1.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 8.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 1.9 | GO:0001741 | XY body(GO:0001741) |
0.4 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 1.1 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 5.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.4 | 1.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 3.8 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 18.3 | GO:0016605 | PML body(GO:0016605) |
0.3 | 1.4 | GO:0033011 | perinuclear theca(GO:0033011) |
0.3 | 5.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 1.3 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.3 | 0.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 0.3 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 1.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 2.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 3.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 1.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 2.6 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.3 | 0.6 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.3 | 1.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 0.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 0.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 5.3 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.3 | 2.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 1.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 1.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 3.4 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.3 | 0.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 6.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 36.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 9.3 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 0.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 0.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 0.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 13.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 1.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 3.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.3 | 5.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 2.3 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 2.0 | GO:0030286 | dynein complex(GO:0030286) |
0.3 | 4.3 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 1.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 1.4 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.2 | 2.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 2.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 3.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 1.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 1.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 1.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 2.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.7 | GO:0001652 | granular component(GO:0001652) |
0.2 | 4.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.2 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.2 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.9 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 0.7 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 4.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.7 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.7 | GO:0022624 | proteasome activator complex(GO:0008537) proteasome accessory complex(GO:0022624) |
0.2 | 0.2 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.2 | 2.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.7 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 1.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.2 | 1.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 2.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 0.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 5.4 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.2 | 2.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 7.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 1.2 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.2 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 1.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 2.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.4 | GO:0030684 | preribosome(GO:0030684) |
0.2 | 1.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 0.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 15.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 1.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 0.2 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 0.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 0.7 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 2.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 0.4 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.2 | 1.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 6.9 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 4.3 | GO:1902493 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.2 | 1.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 6.6 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 1.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.2 | 2.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 6.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 14.6 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 0.7 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 1.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 2.1 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.2 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 3.3 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.2 | 0.3 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.2 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 17.1 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 1.1 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 1.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 1.6 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 1.6 | GO:0005844 | polysome(GO:0005844) |
0.1 | 5.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.4 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.4 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 0.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 11.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 1.4 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.1 | 0.1 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 0.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 5.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 2.4 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 7.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.4 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.1 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.8 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 11.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 4.0 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 5.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 202.3 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 1.2 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 1.0 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 0.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 2.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 1.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 8.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.8 | GO:0016529 | sarcoplasm(GO:0016528) sarcoplasmic reticulum(GO:0016529) |
0.1 | 82.1 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 1.3 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 3.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 1.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.5 | GO:0098573 | integral component of mitochondrial membrane(GO:0032592) intrinsic component of mitochondrial membrane(GO:0098573) |
0.1 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 12.1 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.1 | 6.1 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 0.3 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 1.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 2.1 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.1 | 0.3 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 7.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 39.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 6.7 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 2.2 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.1 | 0.6 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 249.6 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.1 | GO:0032994 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 0.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 2.7 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 1.9 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 8.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 18.9 | GO:0005773 | vacuole(GO:0005773) |
0.1 | 1.0 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 13.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 246.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.1 | 1.2 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 3.0 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 20.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 2.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 3.2 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.0 | GO:0044304 | main axon(GO:0044304) |
0.0 | 0.1 | GO:0030427 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
2.3 | 13.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
2.2 | 6.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.1 | 6.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.0 | 8.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.9 | 19.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.7 | 21.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.7 | 5.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.7 | 5.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.6 | 6.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.6 | 4.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.4 | 4.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.4 | 4.3 | GO:0033691 | sialic acid binding(GO:0033691) |
1.4 | 4.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
1.4 | 7.0 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.4 | 4.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.2 | 9.9 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
1.2 | 4.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.1 | 3.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.1 | 4.5 | GO:0015925 | galactosidase activity(GO:0015925) |
1.1 | 14.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.1 | 14.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.1 | 3.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
1.0 | 5.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.0 | 2.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.0 | 2.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.0 | 5.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.9 | 7.4 | GO:0005522 | profilin binding(GO:0005522) |
0.9 | 3.7 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.9 | 14.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.9 | 34.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.9 | 41.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.9 | 18.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.9 | 16.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.9 | 4.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.8 | 2.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.8 | 2.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.8 | 1.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.8 | 2.4 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.8 | 6.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.8 | 4.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.8 | 5.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.8 | 3.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.8 | 2.3 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.8 | 9.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.8 | 3.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.7 | 0.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.7 | 0.7 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.7 | 2.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 5.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.7 | 2.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.7 | 2.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.7 | 6.3 | GO:0019864 | IgG binding(GO:0019864) |
0.7 | 2.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.7 | 4.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.7 | 4.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.6 | 4.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 5.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 4.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.6 | 3.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.6 | 3.1 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.6 | 5.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.6 | 1.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.6 | 1.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 1.8 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.6 | 1.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.6 | 1.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.6 | 3.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.6 | 2.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.6 | 1.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.6 | 1.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.6 | 6.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.6 | 2.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 3.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.5 | 2.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 4.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.5 | 1.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.5 | 3.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.5 | 3.1 | GO:0070513 | death domain binding(GO:0070513) |
0.5 | 3.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 6.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.5 | 1.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 4.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 1.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 1.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 1.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.5 | 1.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 1.0 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.5 | 2.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 8.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 2.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 1.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 8.8 | GO:0043621 | protein self-association(GO:0043621) |
0.5 | 1.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 3.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.5 | 1.9 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.5 | 1.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 2.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.5 | 2.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 24.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 2.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 0.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 4.0 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.4 | 11.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 2.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.8 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.4 | 1.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.4 | 1.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 1.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 2.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 3.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.4 | 0.4 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.4 | 1.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 1.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 2.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.4 | 1.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 2.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 2.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.4 | 1.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 0.4 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.4 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 0.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.4 | 0.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.4 | 2.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 1.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 2.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 1.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.4 | 2.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 1.2 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 3.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.4 | 1.6 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.4 | 11.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.4 | 5.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 2.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 1.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 1.9 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.4 | 4.2 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 4.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 1.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.4 | 6.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.4 | 2.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 2.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 1.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 1.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 1.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.4 | 1.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.4 | 1.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.4 | 1.1 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 9.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 1.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 0.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 4.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 2.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 3.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 3.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 1.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 4.1 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.3 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 1.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 1.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 1.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.3 | 1.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 1.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 1.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 28.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 1.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 1.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 0.3 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.3 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 9.5 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 2.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 2.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 17.2 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 1.6 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.3 | 0.9 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 3.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 1.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.3 | 0.9 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 1.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 1.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 1.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 0.9 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.3 | 0.6 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 1.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 2.1 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.3 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 1.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 0.3 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 3.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 2.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 0.9 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 0.6 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 0.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 1.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 2.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 0.6 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 1.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 0.9 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.3 | 1.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 2.6 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.3 | 2.3 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.3 | 0.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 3.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 1.7 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 2.5 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.3 | 0.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 1.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 2.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 2.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 2.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 1.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 0.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 1.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.3 | 0.8 | GO:0004802 | transketolase activity(GO:0004802) |
0.3 | 1.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 2.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 2.9 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 3.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 0.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.3 | 4.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 3.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 0.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 0.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 1.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.3 | 0.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 1.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 0.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 3.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 0.5 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.3 | 1.3 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.2 | 1.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 3.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.2 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.2 | 1.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 1.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 1.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 14.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 1.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 1.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.7 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 5.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 1.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 3.5 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.2 | 4.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 1.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 2.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 1.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 1.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 2.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 2.2 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 3.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 1.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 1.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 2.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 2.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 3.3 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.2 | 23.5 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.2 | 0.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.2 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.2 | 6.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 5.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 2.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 0.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 1.0 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 0.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 1.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 2.6 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 1.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 1.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 3.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.0 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 5.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 3.8 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.6 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 3.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 0.4 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.2 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 1.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 1.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.2 | 4.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 3.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 4.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 0.7 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.2 | 1.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 1.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.2 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 1.7 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 0.9 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 2.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 2.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.7 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 1.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 6.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 3.0 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 3.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 3.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.5 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.5 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 1.9 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.2 | 0.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 0.7 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.2 | 1.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 0.7 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 2.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 5.8 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 5.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 1.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.2 | GO:0032407 | mismatch repair complex binding(GO:0032404) MutSalpha complex binding(GO:0032407) |
0.2 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 2.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.9 | GO:0046970 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 2.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 1.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.2 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 46.2 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 1.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.5 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.2 | 1.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 7.0 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.2 | 5.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 89.3 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 1.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.7 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 1.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.7 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 1.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 1.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.6 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.4 | GO:0008200 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
0.1 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.4 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 1.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 6.1 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.7 | GO:0004396 | hexokinase activity(GO:0004396) |
0.1 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 13.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 4.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 1.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 3.8 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.4 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 2.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.2 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.1 | 1.0 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.6 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 2.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 1.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.2 | GO:0019104 | uracil DNA N-glycosylase activity(GO:0004844) DNA N-glycosylase activity(GO:0019104) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.6 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 2.4 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 0.4 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 2.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 3.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 1.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 19.9 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 2.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 1.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 2.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 1.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.6 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.2 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 2.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 6.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 1.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.4 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 19.9 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.1 | 0.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 2.7 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 1.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 3.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.4 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.5 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 145.3 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.1 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.1 | 1.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.4 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 14.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.5 | GO:0032561 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.1 | 3.1 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 1.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 1.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.8 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.7 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.2 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 3.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 1.6 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.0 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.1 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.1 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 17.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.8 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 1.9 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 1.1 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 0.2 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 2.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.1 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.0 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 4.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 2.7 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.4 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.0 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 113.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.7 | 24.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.5 | 16.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.4 | 31.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.4 | 25.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.3 | 2.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.0 | 40.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.0 | 3.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.9 | 25.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.9 | 20.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.9 | 26.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.8 | 5.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.8 | 24.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 17.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.7 | 8.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.7 | 9.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.6 | 7.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.6 | 0.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 7.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.6 | 3.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 3.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.5 | 23.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 11.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 6.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 5.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 0.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.5 | 3.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 3.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 4.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 10.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 6.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 4.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.4 | 5.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.4 | 4.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 15.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 6.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 2.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 1.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 4.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 2.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 2.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 4.8 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 2.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 2.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 3.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 2.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 7.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 3.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 1.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 2.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 2.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 1.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 0.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 2.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 6.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 1.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 3.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 1.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 2.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 6.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 3.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 2.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 3.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 2.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 4.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 4.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 3.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 2.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 4.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 2.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 4.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.6 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 2.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 6.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
2.8 | 22.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
2.6 | 10.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
2.2 | 56.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.4 | 33.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.2 | 17.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.2 | 9.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.1 | 1.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.9 | 19.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.9 | 21.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.9 | 9.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.8 | 8.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 10.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.8 | 20.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.8 | 11.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.8 | 2.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.8 | 10.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.7 | 15.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.7 | 2.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.7 | 13.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.6 | 12.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.6 | 28.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.6 | 28.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.6 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.6 | 0.6 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.6 | 11.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.6 | 7.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.5 | 6.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.5 | 4.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 8.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 1.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 4.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.5 | 4.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.5 | 2.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 4.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.5 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 4.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 0.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 17.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.5 | 12.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 1.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.4 | 13.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 7.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.4 | 4.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 5.4 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.4 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.4 | 4.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 2.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 4.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 5.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.4 | 0.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.4 | 18.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 1.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 6.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.4 | 5.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 1.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 4.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 0.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 0.7 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.3 | 4.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 3.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 2.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 3.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 13.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 0.6 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.3 | 1.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 4.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 0.9 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.3 | 5.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 3.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 17.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 3.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 7.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.3 | 12.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.3 | 4.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.3 | 0.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 7.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 8.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 2.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 7.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 3.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 9.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 4.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 0.8 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.3 | 0.3 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.2 | 3.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 1.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 3.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 1.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 4.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 3.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 16.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 2.3 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 0.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 3.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 2.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 0.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 3.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 3.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 2.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 3.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 1.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 2.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 0.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 5.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 0.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 1.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.2 | 2.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 3.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 1.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 7.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 1.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 1.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 3.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 10.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 2.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.0 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 1.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 5.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 3.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 6.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 3.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 16.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 5.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.4 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 3.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 2.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.3 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 1.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.8 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 8.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.4 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 2.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 8.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 6.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 2.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 4.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 2.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 4.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 4.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 5.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 1.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 13.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 14.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 1.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.8 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.6 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.4 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.5 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |